Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

Clinical trial NCT00412854 · COMPLETED

Trial details

NCT number: NCT00412854
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Diphtheria Acellular Pertussis

Start date: 2007-01-03
Primary completion: 2007-06-01
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.